Azerbaijan plans to localize production of 3 types of insulin

Russian companies GEROPHARM and R-Pharm (part of the R-Pharm group of companies) have announced a strategic partnership in the field of localization of drugs for the treatment of socially significant diseases in Azerbaijan, Report informs referring to the message of GEROPHARM.

"The agreement between the parties envisages the localization of secondary packaging processes for three types of insulin at the R-Pharm plant in Azerbaijan: RinGlar (insulin glargine), RinFast (insulin aspart), RinFast Mix (two-phase insulin aspart), as well as the beginning of commercial sales of drugs for the treatment of diabetes," the message says.

At the moment, the first production campaign of localized insulins has been carried out, the drugs have already been introduced into civil circulation: According to the State Statistics Committee, in 2023, the number of patients with diabetes in Azerbaijan exceeded 320,000 people, of which 30,000 patients were diagnosed with insulin-dependent diabetes.

The Russian-Azerbaijani partnership is aimed at increasing the availability of modern and effective medicines for citizens suffering from this disease. Localization of production of foreign pharmaceuticals in Azerbaijan is an important stage that helps provide local patients with high-quality medicines that meet international standards.

"GEROPHARM is the largest full-cycle insulin manufacturer in the CIS, and we are ready to share our expertise in this matter with our partners. We hope that our joint efforts with R-PHARM will make a significant contribution to strengthening the national healthcare of Azerbaijan and improving the quality of life of patients with diabetes," said Petr Rodionov, CEO of GEROPHARM.

The R-Pharm pharmaceutical complex in Baku is one of the most modern plants in the CIS, including production, laboratory and logistics units. The area of ​​the plant with advanced equipment is 4.6 hectares, and its output capacity exceeds 250 million units of products per year.